These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9104059)

  • 1. Uterine cancer--the KK Hospital experience.
    Tan YY; Ho TH
    Singapore Med J; 1996 Dec; 37(6):600-3. PubMed ID: 9104059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mixed Mullerian tumours of the uterus--a ten-year experience.
    Ho SP; Ho TH
    Singapore Med J; 2002 Sep; 43(9):452-6. PubMed ID: 12568422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
    Clement PB; Zubovits JT; Young RH; Scully RE
    Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
    Aquino-Parsons C; Lim P; Wong F; Mildenberger M
    Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
    Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
    Page BR; Pappas L; Cooke EW; Gaffney DK
    Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.
    Ueda SM; Kapp DS; Cheung MK; Shin JY; Osann K; Husain A; Teng NN; Berek JS; Chan JK
    Am J Obstet Gynecol; 2008 Feb; 198(2):218.e1-6. PubMed ID: 18226630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
    Silva EG; Young RH
    Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
    Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
    Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.